Literature DB >> 12390867

Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy.

Akira Tokumura1, Yumi Kanaya, Maki Miyake, Shuji Yamano, Minoru Irahara, Kenji Fukuzawa.   

Abstract

Lysophosphatidic acid (LPA) is a prototype of the lysophospholipid mediator family and has multiple effects in the female reproductive system. Although several metabolic routes have been reported for intracellular formation of LPA, a unique route involving lysophospholipase D, an extracellular enzyme that produces LPA in blood and body fluids, is particularly intriguing for its agonistic role. In this study, using an assay with radioactive palmitoyl-lysophosphatidylcholine, we found that lysophospholipase D activity producing palmitoyl-LPA in human serum gradually increased during pregnancy. Elevated activity of lysophospholipase D was not caused by changes in levels of their precursors, lysophosphatidylcholines, in nonpregnant women or in pregnant women at different gestational periods. With increasing length of gestation, the elevated activity in pregnant women was found to produce increasing proportions of LPA with a palmitoyl group versus other LPAs. These results suggest that LPA formed by increased activity of lysophospholipase D in blood might participate in maintenance of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390867     DOI: 10.1095/biolreprod.102.004051

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  27 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2).

Authors:  Zhengshan Zhao; Jinwoo Choi; Chunying Zhao; Zhongmin Alex Ma
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

Review 3.  Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer.

Authors:  Glenn D Prestwich; Joanna Gajewiak; Honglu Zhang; Xiaoyu Xu; Guanghui Yang; Monica Serban
Journal:  Biochim Biophys Acta       Date:  2008-04-08

Review 4.  Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.

Authors:  Xiaoqin Ye; Jerold Chun
Journal:  Trends Endocrinol Metab       Date:  2010-01       Impact factor: 12.015

Review 5.  Lysophosphatidic acid in vascular development and disease.

Authors:  Siew T Teo; Yun C Yung; Deron R Herr; Jerold Chun
Journal:  IUBMB Life       Date:  2009-08       Impact factor: 3.885

6.  Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.

Authors:  Lauren E Ragle; Dilip J Palanisamy; Margaux J Joe; Rachel S Stein; Derek D Norman; Gabor Tigyi; Daniel L Baker; Abby L Parrill
Journal:  Bioorg Med Chem       Date:  2016-08-04       Impact factor: 3.641

7.  Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo.

Authors:  Honglu Zhang; Xiaoyu Xu; Joanna Gajewiak; Ryoko Tsukahara; Yuko Fujiwara; Jianxiong Liu; James I Fells; Donna Perygin; Abby L Parrill; Gabor Tigyi; Glenn D Prestwich
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

Review 8.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

9.  The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles.

Authors:  Roberto Matorras; Ibon Martinez-Arranz; Enara Arretxe; Marta Iruarrizaga-Lejarreta; Blanca Corral; Jone Ibañez-Perez; Antonia Exposito; Begoña Prieto; Felix Elortza; Cristina Alonso
Journal:  J Assist Reprod Genet       Date:  2019-12-21       Impact factor: 3.412

10.  Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.

Authors:  Thomas M McIntyre; Aaron V Pontsler; Adriana R Silva; Andy St Hilaire; Yong Xu; Jerald C Hinshaw; Guy A Zimmerman; Kotaro Hama; Junken Aoki; Hiroyuki Arai; Glenn D Prestwich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.